HD-OPM Archive
Topics › Aspirin, antiplatelets & blood thinners

Platelet reactivity score (PRESS) predicts cardiovascular events in PAD patients

Gokhan Can · Aug 20, 2024 · ♥ 6 reactions · 19 comments · original Facebook post
Aspirin, antiplatelets & blood thinnersBlood vessels, circulation & endothelium
AI summary & key facts

NYU researchers developed PRESS, combining platelet aggregation responses and RNA sequencing, to detect platelet hyperreactivity. In PAD patients, hyperreactive platelets predicted more major adverse cardiac or limb events within 30 days of revascularization, and PRESS above the median carried a 90% higher risk of major events over 18 months. It might help target aspirin.

A Novel Platelet Hyper-activity Score Predicts Cardiovascular Risk

(Platelet hyperactivity is a big deal in clotting risk. I'm a fan of Aspirin, Alpha KetoGlutarate supplement, etc as potential aids.)

Researchers at NYU Grossman School of Medicine have developed a novel blood platelet scoring system called the Platelet Reactivity ExpresSion Score (PRESS) that can detect previously unmeasured risks of heart attack and stroke. This new system addresses the challenge of measuring platelet hyperreactivity, which contributes to abnormal clotting and cardiovascular events. PRESS combines platelet aggregation responses and RNA sequencing data to reliably predict platelet hyperreactivity across populations. The study, published in Nature Communications, found that patients with peripheral artery disease (PAD) who had hyperreactive platelets (>60% aggregation in response to 0.4 μM epinephrine) had a significantly higher incidence of major adverse cardiac or limb events (MACLE) within 30 days after lower extremity revascularization procedures.

The researchers validated PRESS in various clinical contexts, including patients with atherosclerosis, systemic lupus erythematosus, and COVID-19. Importantly, PRESS was associated with an increased risk of future cardiovascular events in PAD patients, even after adjusting for various clinical factors. Patients with PRESS scores above the median had a 90% higher risk of experiencing a major cardiovascular event during a median follow-up of 18 months. This new scoring system could help physicians better target anti-platelet treatments like aspirin to patients most likely to benefit, potentially improving the balance between protection against heart attacks and increased bleeding risk.

Article:

medicalxpress.comBlood platelet score previously unmeasuredmedicalxpress.com

Paper:

Paper · Nat Commun · 2024A Platelet Reactivity ExpreSsion Score derived from patients with peripheral artery disease predicts cardiovascular risknature.com

Research cited

#platelets#cardiovascular#heartattack#aspirin#supplements#stroke#atherosclerosis#covid
← newer: Comment: viral infections and aging, and a Novavax vaccine polder: Over a third of 'low-risk' adults had coronary plaque; low L →